Aaron graduated with his PhD in the Department of Biochemistry and Molecular Genetics at the University of Colorado Anschutz Medical Campus. He then completed a post-doctoral fellowship at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences with a focus on characterizing sub-visible particles in protein therapeutics. Aaron then worked as a scientist at KBI Biopharma, Inc. in the Particle Characterization Core focusing on forensic particle analysis, biophysical characterization, and stability of biotherapeutics. He recently began as a Senior Scientist at Umoja Biopharma in Drug Product Development where he focuses on drug product compatibility, stability, and process improvements for a novel lentiviral vector drug product.
Reservation Policy & Attendance Limit: This event has an attendance limit of 300 people and seats will be reserved on a first-come, first-served basis. Please be sure to register as soon as possible to reserve your seat and ensure your attendance.
*We strive to be inclusive. All are welcome to attend!